| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.004 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.13 | 0.004 |